Priorities for hearing loss prevention and estimates of global cause-specific burdens of hearing loss: a systematic rapid review-Reference-Cited by-同舟云学术

Priorities for hearing loss prevention and estimates of global cause-specific burdens of hearing loss: a systematic rapid review

Published:2024-02 Issue:2 Volume:12 Page:e217-e225
ISSN:2214-109X
Container-title:The Lancet Global Health
language:en
Short-container-title:The Lancet Global Health

Author:

Prasad Kavita,Borre Ethan D,Dillard Lauren K,Ayer Austin,Der Carolina,Bainbridge Kathleen E,McMahon Catherine M,Tucci Debara L,Wilson Blake S,Schmidler Gillian D Sanders,Saunders James

Funder

National Institutes of Health

National Institute on Deafness and Other Communication Disorders

National Institute on Aging

Publisher

Elsevier BV

Reference47 articles.

1. Hearing loss prevalence and years lived with disability, 1990–2019: findings from the Global Burden of Disease Study 2019;Haile;Lancet,2021

2. Global burden of childhood hearing impairment and disease control priorities for developing countries;Olusanya;Lancet,2007

3. Aging and hearing health: the life-course approach.;Davis;Gerontologist,2016

4. World report on hearing;WHO,2021

5. A Lancet Commission to address the global burden of hearing loss;Wilson;Lancet,2019

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation of Noise Induced Hearing Loss Among Power Loom Industry Workers in Tamil Nadu, India;Indian Journal of Otolaryngology and Head & Neck Surgery;2024-09-12

2. Identifying data elements and key features to design a telerehabilitation system for speech and language disorders in children with hearing impairments in Iran: A cross‐sectional study;Health Science Reports;2024-09

3. Multiple mechanisms of aminoglycoside ototoxicity are distinguished by subcellular localization of action;2024-05-31

4. Hearing Loss: Self‐Reported Onset and Etiology Among Older Adults in the United States;OTO Open;2024-04

5. Aminoglycosides, deafness, and non-tuberculous mycobacteria;The Lancet Global Health;2024-04